SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-025310
Filing Date
2019-05-10
Accepted
2019-05-10 17:01:23
Documents
46
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv520507_10q.htm 10-Q 330201
2 EXHIBIT 31.1 tv520507_ex31-1.htm EX-31.1 7476
3 EXHIBIT 31.2 tv520507_ex31-2.htm EX-31.2 7455
4 EXHIBIT 32.1 tv520507_ex32-1.htm EX-32.1 3924
5 EXHIBIT 32.2 tv520507_ex32-2.htm EX-32.2 3926
  Complete submission text file 0001144204-19-025310.txt   2607871

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcli-20190331.xml EX-101.INS 569947
7 XBRL TAXONOMY EXTENSION SCHEMA bcli-20190331.xsd EX-101.SCH 25678
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20190331_cal.xml EX-101.CAL 24159
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20190331_def.xml EX-101.DEF 142158
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20190331_lab.xml EX-101.LAB 205390
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20190331_pre.xml EX-101.PRE 176540
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 19815811
SIC: 2836 Biological Products, (No Diagnostic Substances)